Gorakhpur infant deaths: Allahabad HC grants bail to Dr Kafeel Khan

Agencies
April 25, 2018

Allahabad, Apr 25: The Allahabad high court on Wednesday granted bail to Dr Kafeel Khan, who had been booked in connection with the death of children due to lack of oxygen at the Gorakhpur BRD Medical College last August.

Earlier, Dr Kafeel Khan - who has been in jail in the BRD Medical College case involving death of 63 children due to disruption in oxygen supply - had been brought to Gorakhpur district hospital for medical checkup under strict security on April 19.

Dr Khan was brought to the hospital two days after his wife had alleged that her jailed husband was being denied medical care.

The district hospital's cardiologist Dr K K Shahi had tested his blood pressure, carried out other tests and advised him to undergo complete lipid profile test to ascertain risks of heart ailments.

'Being framed'

After the tests, the police tried to take him away without any media interaction but on the way from cardiology department to the police vehicle, he told reporters present there that he was being framed.

"It is complete administrative failure and I have been framed. When the budget was not released from higher level, where from the payment could have been made (for oxygen cylinders)?" he asked.

Asked if the jail administration was providing medicines to him, he replied in the affirmative.

"Yes, they are giving (medicines)," he said.

Soon after, the police bundled him into the vehicle and drove away.

He is being denied medical care: Wife

Dr Khan's wife Dr Shabistan Khan on Tuesday had alleged at a press conference at her home that her husband and other doctors were being denied medical care in jail.

The district prison authorities, however, had rejected the charges.

In her press conference, Dr Shabistan had apprehended that the doctors lodged in the prison might be "killed."

She said her husband suffered a heart stroke on March 29 but was not given proper treatment.

"Former BRD Medical College principal, Dr Rajiv Mishra, is suffering from liver disease and diabetes but he is also not getting proper medical attention," she had claimed.

She had also said another accused, Dr Purnima Shukla, who is suffering from a hairline fracture, was also not getting the requisite medical attention.

Dr Kafeel is among the nine accused in the BRD Medical College and Hospital case involving death of 63 children, including infants, in August 2017 due to disruption in supply of oxygen owing to non-payment of dues to the vendor.

The state-run medical college is the single largest government-aided facility in Gorakhpur which also attends to the patients from nearby areas like Maharajganj, Deoria, Kushinagar, Basti, Siddharthnagar, Sant Kabirnagar, Ballia, certain areas of Bihar like Gopalganj and Siwan, besides border areas in neighboring Nepal.

Comments

zahoor ahmed,K…
 - 
Wednesday, 25 Apr 2018

Health sector in Modi and Yogi Raj. Beware, Both are coming Karnatak to convert to UP.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 9,2020

New Delhi, Jan 9: Amazon founder and CEO Jeff Bezos will be visiting India next week and is likely to meet Prime Minister Narendra Modi and officials, besides industry leaders, according to sources.

The top executive will also attend SMBhav – an event focussing on small and medium businesses in India - that is slated for January 15-16 in the capital city.

When contacted, Amazon declined to comment.

Amazon, which has seen significant growth in its business in India, has also witnessed protest from a section of traders in the country who claim that e-commerce giants including Amazon and Walmart-owned Flipkart offer deep discounts and engage in unfair business practices.

Last year, the government had tightened rules for e-commerce marketplaces with foreign investment. These rules barred such platforms from offering products of sellers in which they hold a stake and banned exclusive marketing arrangements among other clauses. Following this, Amazon restructured its joint ventures to ensure compliance.

Bezos is likely to discuss regulatory issues in his meeting with the government officials.

He is also slated to engage with SMBs during the SMBhav event. The event - which will focus on discussions around how technology adoption can enable SMBs in India - is slated to see participation from industry experts, policymakers, solution providers and Amazon leadership.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 14,2020

New Delhi, Mar 14: A Delhi court on Friday granted bail to three alleged members of the Popular Front of India (PFI) -- Parvez (Delhi President), Iliyas (Delhi Secretary) and Danish -- in connection with the organization's role in the northeast Delhi violence last month.

Metropolitan Magistrate Prabhdeep Kaur granted bail to all three accused on furnishing personal bail bonds of Rs 30,000 each.

The court said that "Investigating Officer (IO) has nowhere mentioned that any of the non-bailable offences has been disclosed or has come out during investigation till now, therefore, accused be enlarged on bail."

According to police, the three men were arrested for allegedly spreading fake propaganda during the anti-CAA protests.

Delhi police, while opposing bail and seeking remand, stated that police custody is required because accused were involved in a conspiracy of communal riots which resulted in the death of 50 innocent people and injuries to approximately 300 persons and huge loss of government and public properties.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.